Allergic reactions to metamizole: Immediate and delayed responses

International Archives of Allergy and Immunology

Volumn 169, Issue 4, 2016, Pages 223-230

  Blanca López, Natalia ^a   Pérez Sánchez, Natalia ^b   Agúndez, José Augusto ^c   García Martin, Elena ^c   Torres, María José ^b   Cornejo García, José Antonio ^b   Perkins, James R ^b   Miranda, Miguel Angel ^d   Andreu, Inmaculada ^d   Mayorga, Cristobalina ^b   Canto, Gabriela ^a   Blanca, Miguel ^b   Doña, Inmaculada ^b  

^a HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c UNIVERSITY OF EXTREMADURA   (Spain)

^d CSIC   (Spain)

Author keywords

Basophil activation test; Drug provocation test; Metamizole; Selective hypersensitivity; Skin test

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRONE;

ADULT; AGED; ALLERGY TEST; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BASOPHIL ACTIVATION TEST; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG PROVOCATION TEST; DRUG TOLERANCE; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INTRACUTANEOUS TEST; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; SKIN PRICK TEST; SKIN TEST; URTICARIA; ADOLESCENT; ALGORITHM; CLINICAL DECISION MAKING; DISEASE MANAGEMENT; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGY; PHENOTYPE; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANAPHYLAXIS; CLINICAL DECISION-MAKING; DIPYRONE; DISEASE MANAGEMENT; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; PHENOTYPE; SKIN TESTS; TIME FACTORS; YOUNG ADULT;

EID: 84975222144     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000444798     Document Type: Article

References (44)

1. Thong BY, Tan TC: Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 2011; 71: 684-700.
2. Dona I, Blanca-Lopez N, Torres MJ, Garcia-Campos J, Garcia-Nunez I, Gomez F, et al: Drug hypersensitivity reactions: Response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012; 22: 363-371.
3. Zambonino MA, Torres MJ, Munoz C, Requena G, Mayorga C, Posadas T, et al: Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol 2013; 24: 151-159.
4. Antunez C, Martin E, Cornejo-Garcia JA, Blanca-Lopez N, R-Pena R, Mayorga C, et al: Immediate hypersensitivity reactions to penicillins and other betalactams. Curr Pharm Des 2006; 12: 3327-3333.
5. Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, et al: Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013; 68: 1219-1232.
6. Canto MG, Andreu I, Fernandez J, Blanca M: Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol 2009; 9: 293-297.
7. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al: IgEmediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003; 111: 882-888.
8. Schneider CH, Kasper MF, de Weck, AL, Rolli H, Angst BD: Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione cross-reactivity relationships. Allergy 1987; 42: 597-603.
9. Blanca M, Perez E, Garcia JJ, Miranda A, Terrados S, Vega JM, et al: Angioedema and IgE antibodies to aspirin: A case report. Ann Allergy 1989; 62: 295-298.
10. Harrer A, Lang R, Grims R, Braitsch M, Hawranek T, Aberer W, et al: Diclofenac hypersensitivity: Antibody responses to the parent drug and relevant metabolites. PLoS One 2010; 5:e13707.
11. Posadas SJ, Padial A, Torres MJ, Mayorga C, Leyva L, Sanchez E, et al: Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002; 109: 155-161.
12. Gomez E, Blanca-Lopez N, Salas M, Canto G, Campo P, Torres MJ, et al: Induction of accelerated reactions to amoxicillin by T-cell effector mechanisms. Ann Allergy Asthma Immunol 2013; 110: 267-273.
13. Terrados S, Blanca M, Garcia J, Vega J, Torres MJ, Carmona MJ, et al: Nonimmediate reactions to betalactams: prevalence and role of the different penicillins. Allergy 1995; 50: 563- 567.
14. Szczeklik A, Stevenson DD: Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111: 913-921.
15. Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004; 328: 434.
16. Szczeklik A, Sladek K, Dworski R, Nizankowska E, Soja J, Sheller J, et al: Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996; 154: 1608-1614.
17. Sanak M, Gielicz A, Bochenek G, Kaszuba M, Nizankowska-Mogilnicka E, Szczeklik A: Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype. J Allergy Clin Immunol 2011; 127: 1141-1147.
18. Blanca-Lopez N, J Torres M, Dona I, Campo P, Rondon C, Seoane Reula ME, et al: Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin Exp Allergy 2013; 43: 85-91.
19. Dona I, Blanca-Lopez N, Torres MJ, Gomez F, Fernandez J, Zambonino MA, et al: NSAIDinduced urticaria/angioedema does not evolve into chronic urticaria: A 12-year follow- up study. Allergy 2014; 69: 438-444.
20. Dona I, Blanca-Lopez N, Cornejo-Garcia JA, Torres MJ, Laguna JJ, Fernandez J, et al: Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41: 86-95.
21. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M: Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998; 28: 1153-1158.
22. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P: General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
23. Gomez E, Blanca-Lopez N, Torres MJ, Requena G, Rondon C, Canto G, et al: Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39: 1217-1224.
24. Ayuso P, Blanca-Lopez N, Dona I, Torres MJ, Gueant-Rodriguez RM, Canto G, et al: Advanced phenotyping in hypersensitivity drug reactions to NSAIDs. Clin Exp Allergy 2013; 43: 1097-1109.
25. Gamboa PM, Sanz ML, Caballero MR, Antepara I, Urrutia I, Jauregui I, et al: Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 2003; 58: 312-317.
26. Gamboa P, Sanz ML, Caballero MR, Urrutia I, Antepara I, Esparza R, et al: The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004; 34: 1448-1457.
27. Sanz ML, Gamboa P, de Weck, AL: A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005; 136: 58-72.
28. Blanca M, Torres MJ, Garcia JJ, Romano A, Mayorga C, de Ramon, E, et al: Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 1999; 103: 918-924.
29. Fernandez TD, Torres MJ, Blanca-Lopez N, Rodriguez-Bada JL, Gomez E, Canto G, et al: Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 2009; 64: 242-248.
30. Ariza A, Fernandez TD, Dona I, Aranda A, Blanca-Lopez N, Melendez L, et al: Basophil activation after nonsteroidal anti-inflammatory drugs stimulation in patients with immediate hypersensitivity reactions to these drugs. Cytometry A 2014; 85: 400-407.
31. Levy M, Zylber-Katz E, Rosenkranz B: Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet 1995; 28: 216- 234.
32. Martinez C, Andreu I, Amo G, Miranda MA, Esguevillas G, Torres MJ, et al: Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole. Biochem Pharmacol 2014; 92: 457-466.
33. Wessel JC, Matyja M, Neugebauer M, Kiefer H, Daldrup T, Tarbah FA, et al: Characterization of oxalic acid derivatives as new metabolites of metamizol (dipyrone) in incubated hen's egg and human. Eur J Pharm Sci 2006; 28: 15-25.
34. Ozkaya-Bayazit E, Bayazit H, Ozarmagan G: Drug related clinical pattern in fixed drug eruption. Eur J Dermatol 2000; 10: 288-291.
35. Gonzalo-Garijo MA, Perez-Calderon R, De Argila D, Rodriguez-Nevado I: Metamizoleinduced acute generalized exanthematous pustulosis. Contact Dermatitis 2003; 49: 47-48.
36. Borja JM, Galindo PA, Gomez E, Feo F: Delayed skin reactions to metamizol. Allergy 2003; 58: 84-85.
37. Dalmau J, Serra-Baldrich E, Roe E, Peramiquel L, Alomar A: Use of patch test in fixed drug eruption due to metamizole (Nolotil). Contact Dermatitis 2006; 54: 127-128.
38. Macias E, Ruiz A, Moreno E, Laffond E, Davila I, Lorente F: Usefulness of intradermal test and patch test in the diagnosis of nonimmediate reactions to metamizol. Allergy 2007; 62: 1462-1464.
39. Romano A, Torres MJ, Castells M, Sanz ML, Blanca M: Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol 2011; 127(3 suppl):S67-S73.
40. Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, et al: Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64: 183-193.
41. Bircher AJ, Scherer Hofmeier K: Drug hypersensitivity reactions: inconsistency in the use of the classification of immediate and nonimmediate reactions. J Allergy Clin Immunol 2012; 129: 263-264.
42. Agundez JA, Martinez C, Benitez J: Metabolism of aminopyrine and derivatives in man: in vivo study of monomorphic and polymorphic metabolic pathways. Xenobiotica 1995; 25: 417-427.
43. Vlahov V, Badian M, Verho M, Bacracheva N: Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium. Eur J Clin Pharmacol 1990; 38: 61-65.
44. Zhu D, Becker WM, Schulz KH, Schubeler K, Schlaak M: Detection of IgE antibodies specific for 1-phenyl-2, 3-dimethyl-3-pyrazoline- 5-one by RAST: A serological diagnostic method for sensitivity to pyrazoline drugs. Asian Pac J Allergy Immunol 1992; 10: 95-101.